Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Antiplatelet Therapy Following Stent Implantation
A completed clinical trial update evaluating antiplatelet therapy following stent implantation in patients with acute myocardial infarction …
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: Association Between Telomere Length and Risk of Acute Coronary Syndrome
This update summarizes a completed study investigating whether telomere length is associated with the risk of acute coronary syndrome.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Variation Between Hospitals in Short-term Mortality After Acute Coronary Syndromes: A CALIBER Study
A CALIBER study reports variation between hospitals in short-term mortality after acute coronary syndromes.
-
FDA approval · 2016-05-11FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
The FDA approved a supplemental application filed by Dr. Reddy's Laboratories Inc for clopidogrel bisulfate (generic) to support changes to …
-
FDA approval · 2016-05-11FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for CLOPIDOGREL BISULFATE submitted by Dr. Reddy's Laboratories Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-05-11Clinical Trial Update: Assessment of Thrombotic Status in Patients With Acute Coronary Syndrome
A ClinicalTrials.gov update for a study assessing thrombotic status in patients with Acute Coronary Syndrome; no results or status details a…
-
FDA approval · 2016-05-10FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for clopidogrel bisulfate (generic clopidogrel) from Radha Pharmaceuticals, Inc., indicating approva…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy [Phase 3]
This is an update on a Phase 3 trial comparing otamixaban to unfractionated heparin plus eptifibatide in patients with unstable angina or no…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Trajectory of Positive Psychological States in Patients With ACS
This update reports on a completed clinical trial examining the trajectory of positive psychological states in patients with acute coronary …
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes [Phase 2]
TAK-442 was evaluated in a Phase 2 trial in patients with Acute Coronary Syndrome to assess safety and efficacy. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study [Phase 4]
A Phase 4 clinical trial update comparing sublingual versus traditional oral ticagrelor for platelet reactivity in acute coronary syndromes,…
-
FDA approval · 2016-03-21FDA Approved: BIVALIRUDIN — Supplemental Application (Civica, Inc.)
FDA approved a Civica, Inc.-submitted supplemental application for Bivalirudin, updating its regulatory status for use as an anticoagulant. …
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: ProspEctive First Evaluation in Chest Pain Trial [NA]
The ProspEctive chest pain trial has completed its first evaluation in patients with chest pain and suspected acute coronary syndrome.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay [NA]
This clinical trial update from NCT02699008 notes high on-treatment platelet reactivity identified by multiple platelet function assays in a…
-
FDA approval · 2016-03-02FDA Approved: KENGREAL — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for KENGREAL (cangrelor) from Chiesi USA, Inc., resulting in an updated labeling for the product.
-
CLINICAL_TRIALS research · 2016-02-25Clinical Trial Update: Circulating microRNAs in Patients With STEMI Complicated With Cardiogenic Shock
A clinical trial updating on circulating microRNAs in patients with ST-elevation myocardial infarction complicated by cardiogenic shock.
-
CLINICAL_TRIALS research · 2016-02-23Clinical Trial Update: 18F-NaF-PET for Identification of TCFA
A clinical trial entry describes a study using 18F-NaF PET imaging to identify thin-cap fibroatheromas in patients with acute coronary syndr…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: A Comparison of the TIMI, GRACE and HEART Scores
A completed clinical trial evaluating how well TIMI, GRACE, and HEART risk scores predict outcomes in patients with Acute Coronary Syndrome.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial [Phase 3]
Phase 3 European Ambulance Acute Coronary Syndrome angiography trial update from The Medicines Company; study status is completed with resul…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Acute Coronary Syndrome [Phase 2]
Phase 2 trial assessing safety, tolerability, and effects on markers of intravascular inflammation in patients with acute coronary syndrome.
-
CLINICAL_TRIALS research · 2016-01-29Clinical Trial Update: Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome
A completed clinical trial update providing longitudinal data on treatment patterns and events after acute coronary syndrome, focusing on AD…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression [Phase 4]
Phase 4 trial evaluating antidepressants to promote recovery in patients with acute coronary syndrome and depression has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL) [Phase 4]
IDEAL is a Phase 4 trial evaluating ischemia-driven enoxaparin therapy in acute coronary syndrome presenting as low risk. The study focuses …
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Phase III Acute Coronary Syndrome [Phase 3]
A Phase III trial in Acute Coronary Syndrome was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Comparison Between High-sensitivity Cardiac Troponin T and Standard Tnl Assays in Early Cardiac Ischemia Detection
The study compares high-sensitivity troponin T to standard troponin I assays for early detection of cardiac ischemia in acute coronary syndr…